Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

 The latest in cell & gene research, from advanced therapies through to the latest developments in cell & gene research, therapies & manufacturing

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Cell Therapy Development

Regulation and Policy Interview with Scott Burger, Principal of Advanced Cell and Gene Therapy

Scott Burger, Principal of Advanced Cell and Gene Therapy, discusses some of the recent trends in regulation and policy surrounding cell and gene therapy development.
Read More
Cell Therapy Development

CHO Cells and Engineering Cell Line Approaches: Addressing Challenges in Manufacturing

Regulatory approval is, as ever, a crucial factor to bear in mind during the later phases of clinical trials. Regardless of the cell line approach chosen, keeping a consistent process and product output is key for establishing a successful project without it being hamstrung at the final hurdle.
Read More
Cell Therapy Development

Jemperli Granted FDA Approval in Endometrial Cancer Applications

Following FDA approval for the use of Jemperli in the context of patients with dMMR recurrent or advanced scenarios, the therapeutic's applications are being investigated in registrational enabling studies as monotherapy and as part of combination regimens.
Read More
Cell Therapy Development

Senti Streamline Their CAR-NK Cell Therapy Program to Focus on Acute Myeloid Leukaemia

By dropping down from three to two ongoing cell therapies in clinical development, Senti aims to ensure its current financial reserves last into 2024.
Read More
Cell Therapy Development

Funding Boost Announced for Experimental Cancer Medicine Centres

Potential treatments which may benefit from the funding increase include CAR-T cell therapies and checkpoint inhibitors, with the end goal of clinical use in cancer patients.
Read More
Cell Therapy Development

Good Manufacturing Practices: Overcoming Regulatory Approval Hurdles

Securing regulatory approval is often the end goal in the development of a new therapeutic product. But what steps can be taken to avoid some of the common curveballs encountered in the industry?
Read More
Cell Therapy Development

In Conversation With Pedro Caetano Pinto, Lab Lead in Experimental Urology, Universität Greifswald

We interview Pedro-Caetano Pinto, Lab Head at the University of Greifswald to learn more about his work with microphysiological systems for advanced kidney and prostate cancer research.
Read More
Cell Therapy Development

Q and A with Vasiliki E. Kalodimou

Vasiliki Kalodimou of the NCSR DEMOKRITOS, discusses her work in cell therapy analytics, ahead of Oxford Global's Cell Therapy Analytics Event.
Read More
Cell Therapy Development

A Front-End Automation Method for QIAcuity Digital PCR Plate Setup using the QIAgility Liquid Handling Instrument

Read More
Cell Therapy Development

Assessment of the Precision and Sensitivity of QIAcuity® Nanoplate Digital PCR vs. qPCR

Read More
Cell Therapy Development

Biocair: General Services

Read More
Cell Therapy Development

Biocair Case Study: Delivering Personalised Supply Chains for Autologous Cell Therapies

Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things cell & gene